Abstract
In order to analyze the effects of serum ovarian steroid hormones on bone metabolism during the menstrual cycle, we have measured urinary levels of type I collagen cross-linked N-telopeptide (NTx), hydroxylysylpyridinoline (HP), lysylpyridinoline (LP), and hydroxyproline (OH-Pr) in nine healthy Japanese women, aged 22–43 years, with normal ovarian function. The cycles were synchronized by serum LH peaks, and follicular and luteal periods were normalized by lengths. Serum gonadotropins and ovarian sex steroids showed significantly different cyclic variations during the menstrual periods. Urinary NTx remained unchanged during the early follicular period, showed a rise during the mid- and late follicular period, and a fall during the mid- and late luteal periods. There were significant differences in NTx levels between early follicular period and midfollicular period (P<0.01), or late follicular period (P<0.05), and between early luteal period and late luteal period (P<0.05). The levels of HP and LP showed a rise during the early and midfollicular periods and a fall during the midluteal period. The correlation of NTx with urinary OH-Pr was better than with urinary HP or LP (r=0.731 versus r=0.449 or r=0.634). This variation suggests that cyclic changes in serum ovarian sex steroids might modulate bone resorption markers during the menstrual cycle.
Similar content being viewed by others
References
DeMerre LJ, Lotosky FS (1968) Alkaline-phosphatase activity during menstruation. Fertil Steril 19:593–597
Pitkin RM, Reynolds AR, Williams GA, Hargis KG (1978) Calcium-regulating hormones during the menstrual cycle. J Clin Endocrinol Metab 47:626–632
Baran DT, Whyte MP, Haussler MR, Deftos LJ, Slatopolsky E, Avioli LV (1980) Effect of the menstrual cycle on calciumregulating hormones in the normal young woman. J Clin Endocrinol Metab 50:377–379
Gray TK, McAdoo T, Hatley L, Lester GE, Thierry M (1982) Fluctuation of serum concentration of 1,25-dihydroxyvitamin D3 during the menstrual cycle. Am J Obstet Gynecol 144:880–884
Tjellesen L, Christiansen C, Hummer L, Larsen NE (1983) Unchanged biochemical indices of bone turnover despite fluctations in 1,25-dihydroxyvitamin D during the menstrual cycle. Acta Endocrinol (Copenh) 102:476–480
Muse KN, Manolagas SC, Deftos LJ, Alexander N, Yen SSC (1986) Calcium-regulating hormones across the menstrual cycle. J Clin Endocrinol Metab 62:1313–1315
Buchanan JR, Santen RJ, Cavaliere A, Cauffman SW, Greer RB, Demers LM (1986) Interaction between parathyroid hormone and endogenous estrogen in normal women. Metabolism 35:489–494
Nielsen HK, Brixen K, Bouillon R, Mosekilde L (1990) Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab 70:1431–1437
El-Hajj Fuleihan G, Hall JE, Porrino N, Gleason R, Crowley WF Jr (1993) Intact parathyroid hormone levels across the menstrual cycle. J Bone Miner Res 8 (suppl 1):S188
Gorai I, Hosoda K, Chaki O, Minaguchi H (1993) Changes in intact and N-fragment osteocalcin and other biochemical indices during the menstrual cycle. J Bone Miner Res 8 (suppl 1):S290
Singer FR, Schiller AL, Pyle EB, Krane SM (1978) Paget's disease of bone. In: Avioli LV, Krane SM (eds) Metabolic bone disease, vol II. Academic Press, New York, p 489
Deacon AC, Hulme P, Hesp R, Green JR, Tellez M, Reeve J (1987) Estimation of whole body bone resorption rate: a comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis. Clin Chem Acta 166:297–306
Weiss PH, Klein L (1969) The quantitative relationship of urinary peptide hydroxyproline excretion to collagen degradation. J Clin Invest 48:1
Kivirikko KI (1970) Urinary excretion of hydroxyproline in health and disease. Int Rev Connect Tissue Res 5:93–163
Gunja-Smith Z, Boucek RJ (1981) Collagen cross-linking compounds in human urine. Biochem J 197:759–762
Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T (1983) Analyses of pyridinoline, a cross-linking compound of collagen fibers, in human urine. J Biochem 94:1133–1136
Black D, Duncan A, Robins SP (1989) Quantitative analysis of the pyridinium crosslinks of collagen in urine using ionpaired reversed-phase high-performance liquid chromatography. Anal Biochem 169:197–203
Uebelhart D, Gineyts E, Chapuy MC, Delmas PD (1990) Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 8:87–96
Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367–373
Colwell A, Eastell R, Assiri AMA, Russell RGG (1990) Effect of diet on deoxypyridinoline excretion. In: Christiansen C, Overgaard K (eds) Osteoporosis 1990, vol 2. Osteopress Aps, Copenhagen, p 520
Beardsworth LJ, Eyre DR, Dickson IR (1990) Changes with age in the urinary excretion of lysyl-and hydroxylysylpyridinoline: two new markers of bone collagen turnover. J Bone Miner Res 5:671–676
Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR (1992) A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 11:1251–1258
Komm BS, Terpening CH, Benz DJ, Graeme KA, Gallegos A, Kore M, Greene GL, O'Malley BW, Haussler MR (1988) Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81–84
Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal osteoblast cells. Science 241:84–86
Pensler JM, Radosevich JA, Higbee R, Langman CB (1990) Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res 5:797–802
Orimo H, Fujita T, Yoshikawa M (1972) Increased sensitivity of bone to parathyroid hormone in ovariectomized rats. Endocrinology 90:760–763
Apone S, Fevold K, Lee M, Eyre DR (1994) A rapid method for quantifying osteoclast activity in vitro. J Bone Miner Res 9 (suppl 1):S178
Schlemmer A, Hassager C, Jensen SB, Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476–480
Davison JM, Noble MBC (1981) Serial changes in 24-hour creatinine clearance during the normal menstrual cycle and the first trimester of pregnancy. Br J Obstet Gynecol 88:10–17
Paaby P, Möller-Petersen J, Larsen CE, Raffn K (1987) Endogenous overnight creatinine clearance. Serum beta2-microglobulin and serum water during the menstrual cycle. Acta Med Scand 221:191–197
Schlemmer A, Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C (1993) Possible variation in bone resorption during the normal menstrual cycle. Acta Endocrinol (Copenh) 129: 388–392
Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J (1993) Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation to bone histomorphometry. J Bone Miner Res 8:127–132
Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39:635–640
Bernard MP, Myers JC, Chu ML, Ramirez F, Eikenberry EF, Rrockop DJ (1983) Structure of a cDNA for the proα2 chain of human type I collagen. Comparison with chick cDNA forα2 (I) identifies structurally conserved features of the protein and the gene. Biochemistry 22:1139–1145
Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C (1994) Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022–2025
Hassager C, Jensen LT, Pødenphant J, Thomsen K, Christiansen C (1994) The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy. Calcif Tissue Int 54:30–33
Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clements JD, Greenspan SL (1994) Specificity of urinary excretion of cross-linked N-telopeptides of Type I collagen as a marker of bone turnover. Calcif Tissue Int 54:26–29
Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HK, Chesnut CH, Eyre DR (1994) Monitoring bone resorption in early postmenopausal women by an immunoassay for crosslinked collagen peptides in urine. J Bone Miner Res 9:135–141
Johansen JS, Jensen SB, Riis BJ, Christiansen C (1990) Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women. Metabolism 39:1122–1126
Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, Raisz LG (1994) The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366–371
Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF (1993) Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 8:635–641
Delmas PD, Gyneyts E, Bertholin A, Garnero P, Marchand F (1993) Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 8:643–648
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gorai, I., Chaki, O., Nakayama, M. et al. Urinary biochemical markers for bone resorption during the menstrual cycle. Calcif Tissue Int 57, 100–104 (1995). https://doi.org/10.1007/BF00298428
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00298428